()
has been a registered insider since 2003.
As Chief Executive Officer at CRISPR Therapeutics, last made a transaction on 3/23/2026.
InsiderInsights.com Purchase Scorecard
|
|
|
Transaction Date
|
|
Nq |
Hit
Rate
|
Mean
Return
|
Median
Return
|
Range of
Returns
|
Time From
Purchases
|
Nq |
Hit
Rate
|
Mean
Return
|
Median
Return
|
Range of
Returns
|
| 7 |
57% |
18% |
24% |
178 |
1 Year |
7 |
0% |
-- |
-- |
-- |
| 7 |
43% |
15% |
-2% |
150 |
9 Month |
7 |
0% |
-- |
-- |
-- |
| 7 |
71% |
26% |
1% |
240 |
6 Month |
7 |
0% |
-- |
-- |
-- |
| 7 |
29% |
-1% |
-22% |
151 |
3 Month |
7 |
0% |
-- |
-- |
-- |
| 7 |
29% |
5% |
-7% |
113 |
1 Month |
7 |
0% |
-- |
-- |
-- |
| 7 |
57% |
-1% |
1% |
36 |
1 Week |
7 |
0% |
-- |
-- |
-- |
InsiderInsights.com Sales Scorecard
|
|
|
Transaction Date
|
|
Nq |
Hit
Rate
|
Mean
Return
|
Median
Return
|
Range of
Returns
|
Time From
Sales
|
Nq |
Hit
Rate
|
Mean
Return
|
Median
Return
|
Range of
Returns
|
| 40 |
48% |
17% |
6% |
285 |
1 Year |
40 |
0% |
-- |
-- |
-- |
| 40 |
50% |
14% |
1% |
321 |
9 Month |
40 |
0% |
-- |
-- |
-- |
| 43 |
58% |
0% |
-9% |
189 |
6 Month |
43 |
0% |
-- |
-- |
-- |
| 44 |
68% |
-5% |
-9% |
82 |
3 Month |
44 |
0% |
-- |
-- |
-- |
| 48 |
60% |
-1% |
-8% |
66 |
1 Month |
48 |
0% |
-- |
-- |
-- |
| 48 |
58% |
-1% |
-1% |
40 |
1 Week |
48 |
0% |
-- |
-- |
-- |
| Scorecards Updated 4/29/2026 05:07 PM EST |
Latest Transaction Date: |
3/23/2026 |
| Average days between Transaction and Entered Dates: |
2 |
